# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Pierre Le Moyne d'Iberville (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET014-SYN-TD
- Date: 1705-02-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marguerite Delacroix-Boateng, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

New patient visit for recurrent fevers with chills after naval service in malaria-endemic areas, and an expected tropical deployment: history, examination, malaria testing, quantitative G6PD, and an infectious diseases (travel medicine) referral. **S**

## Historical basis

- Pierre Le Moyne d'Iberville was born on July 16, 1661, in Montreal (Ville-Marie), New France, and was baptized there on July 20, 1661. He was the third son of Charles Le Moyne de Longueuil et de Châteauguay and Catherine Thierry. **D**
- The name d'Iberville came from a fief held by his father's family near Dieppe, and d'Ardillières from a property he acquired in Aunis near Rochefort. He was the first person born in Canada to receive the cross of the order of Saint-Louis. **D**
- He fought the English in Hudson Bay and James Bay from 1686: the capture of the James Bay posts in 1686, the Albany River in 1688 to 1689, New Severn in 1690, York Fort (renamed Fort Bourbon) in 1694, and in 1697 the naval battle near York Factory in which his ship, the Pélican, defeated English warships and was itself lost, followed by the surrender of the fort. **D**
- His biographer records that scurvy and exposure killed 25 of the English in the winter of 1688 to 1689 on the Albany River, and that in 1694 at York Fort scurvy killed many men on both sides. **D**
- In 1696 to 1697 he led a campaign against the English: Fort William Henry at Pemaquid capitulated on August 15, 1696, and in Newfoundland St John's surrendered on November 30 after a brief siege; the campaign destroyed 36 settlements, killed about 200 people and took about 700 prisoners. **D**
- He led the expeditions that began the French colony of Louisiana: in April 1699 he chose a site near the entrance of Biloxi Bay, near present-day Ocean Springs, Mississippi, for Fort Maurepas; in 1700 he built a fort on the Mississippi; and on his third voyage he began Fort Saint-Louis at Mobile. He left Louisiana in April 1702 and did not return. **D**
- Sailing from La Rochelle on September 29, 1701, on his third voyage to Louisiana, he was forced by illness to put in at Pensacola. **D**
- His biographer writes that he had attacks of malaria that recurred several times from 1702 to 1705 and that his deteriorating health thwarted planned expeditions to Louisiana; 64 Parishes writes that illness kept him from the expedition of 1703. **D**
- Despite his poor health, he was well enough in 1705 to be entrusted with preparing an armament, and early in 1706 he sailed from France with a squadron of twelve vessels against the English in the West Indies. **D**
- His biographer places the births of three of his children at La Rochelle, in 1698, 1701 and 1705. **D**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He fears another attack of fever at sea, where he would be far from a laboratory and responsible for the squadron. **S**
- He must have every vaccine and certificate that entry to French Guiana and the islands requires before the squadron sails. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- No medications before this visit. **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- late 1701: An illness at sea, nature not recorded, that forced him to put in at port on a voyage to the Gulf of Mexico about three and a half years before intake **D** (CLM-0007)
- 1702 onward: Recurrent attacks of illness over the past three years, described by his biographer as malaria, that kept him from planned voyages **D** (CLM-0008)

## Procedures and immunizations

- No procedures before this visit. **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

Hemoglobin: 13 g/dL (low); White cell count: 5.6 10*3/uL; Platelets: 141 10*3/uL (low); Sodium: 139 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.98 mg/dL; Glucose: 92 mg/dL; ALT: 34 U/L; AST: 29 U/L; Total bilirubin: 1.1 mg/dL; G6PD activity: 11.8 U/g{Hb}; eGFR: 98 mL/min/1.73 m². All results are synthetic.

BP 124/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 68.4 kg; BMI 22.3 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, direct and impatient to be fit for sea; worried that another attack at sea would endanger the deployment. Functional status: Independent; lost about a week of work with each febrile attack. Physical examination is intentionally limited. **S**

## Assessment

1. Recurrent episodes of fever with shaking chills and drenching sweats, three in the past two years, each beginning months after naval service in malaria-endemic areas; the first diagnosed as malaria abroad on a blood smear with the species not recorded and treated with chloroquine alone, the later two treated with chloroquine without testing; the last ended six weeks before intake; afebrile and well at intake; cause not established at intake; infectious diseases consultation requested; status draft. **S**
2. Pre-travel care for a naval deployment, expected to sail early next year, to French Guiana and the French Antilles: yellow fever vaccination required for entry to French Guiana, malaria prevention, dengue, chikungunya and typhus prevention by vector avoidance, food and water safety, and travel vaccines; status draft. **S**

## Plan

- Infectious diseases (travel medicine) consultation in two weeks to establish the cause of the recurrent fevers, advise on antirelapse treatment, and plan pre-travel care for the deployment. Guideline: Treatment of Uncomplicated Malaria (clinical guidance) (2026); The practice of travel medicine: guidelines by the Infectious Diseases Society of America (Hill DR, et al. Clin Infect Dis 2006;43(12):1499-1539) (2006) **S**
- Malaria testing between attacks: thick and thin blood smears, rapid antigen test, and Plasmodium species PCR sent to the reference laboratory; quantitative G6PD activity before any primaquine; blood count, kidney and liver tests. Guideline: Treatment of Uncomplicated Malaria (clinical guidance) (2026) **S**
- Fever action plan: a blood smear the same day for any fever, at home, at sea or after travel; carry a card stating his malaria history. Guideline: Treatment of Uncomplicated Malaria (clinical guidance) (2026); CDC Yellow Book: Health Information for International Travel, 2026 edition. Malaria (2026) **S**

## Guideline basis

- Treatment of Uncomplicated Malaria (clinical guidance) (2026), Centers for Disease Control and Prevention
- CDC Yellow Book: Health Information for International Travel, 2026 edition. Malaria (2026), Centers for Disease Control and Prevention
- The practice of travel medicine: guidelines by the Infectious Diseases Society of America (Hill DR, et al. Clin Infect Dis 2006;43(12):1499-1539) (2006), Infectious Diseases Society of America
